Skip to content

Electromagnetic Stylet Post Market Clinical Followup Study

Electromagnetic Stylet Post Market Clinical Followup Study - EMS-PMCF

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50781
Enrollment
134
Registered
2021-10-13
Start date
2022-03-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydrocephalus Normal-Pressure Hydrocephalus (NPH)

Interventions

None listed

Sponsors

Brainlab A.G.
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Male and female, all age groups • Patient or legally authorized representative has signed the Informed Consent form • Ventricular catheter placement for the indications: o Elevated ICP o Enlarged ventricles o Disruption of the CSF drain of any origin o Ventricular catheter placement for the placement of reservoirs (e.g., Ommaya).

Exclusion criteria

Exclusion criteria: • Patients with slit ventricles (Frontal-Occipital Horn Width Ratio (FOHWR) 0.5) • Patients with preexisting catheter path at the same access • Exclusion criteria for MRI (e.g. pacemaker, recent prosthesis) judged by the treating physician

Design outcomes

Primary

MeasureTime frame
The systematic investigation of prospective data obtained during clinical use of the EM Stylet will be performed by means of catheter placement evaluation on intraoperative or postoperative imaging (MRI or ultrasound). Catheter placement accuracy will be assessed based on following grading system adapted from Hayhurst et al. (Hayhurst et al., 2010): • Grade 1: Perforated catheter part is free floating in cerebrospinal fluid within the ventricle, approximately equidistant from ventricular walls, away from the choroid plexus and a straight trajectory from the burr hole. • Grade 2: Perforated catheter part is attached to a ventricular wall or involves choroid plexus • Grade 3: Perforated catheter part is partially or completely within the brain parenchyma or failed to cannulate the ventricle completely

Secondary

MeasureTime frame
Adverse events and Serious adverse events (all and device related)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)